Skip to main content
OpenTrials

Clinical trial condition

Benign Prostatic Hyperplasia

Explore clinical trials studying Benign Prostatic Hyperplasia. Study availability and eligibility vary by location and protocol.

277 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Benign Prostatic Hyperplasia trial results

Completed

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

NCT00077012

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • Raymond Fay, MD, Inc San Francisco, California, United States
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
  • Advanced Research Institute Inc New Port Richey, Florida, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details
Completed

A Study of Tadalafil in Benign Prostatic Hyperplasia

NCT01183650

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munich, Germany
View Trial Details
Completed

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

NCT00527605

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Wuhan, Hubei, China
  • GSK Investigational Site Nanjing, Jiangsu, China
  • GSK Investigational Site Hangzhou, Zhejiang, China
View Trial Details
Completed

A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia

NCT00855582

Conditions
Benign Prostatic Hyperplasia, Erectile Dysfunction, Genital Diseases, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anchorage, Alaska, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Mesa, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
View all 52 locations
View Trial Details
Completed

Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia

NCT00861757

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyōgo, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kaohsiung City, Taiwan
View Trial Details
Completed

Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto

NCT00797394

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • Recherches Cliniques Theradev Granby, Quebec, Canada
  • Urology South Shore Research Greenfield Park, Quebec, Canada
  • Les Urologues Associés du CHUM Montreal, Quebec, Canada
  • Clinique d'urologie Berger Québec, Quebec, Canada
View Trial Details
Completed

Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension

NCT00783094

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan
View Trial Details

Related conditions